144 related articles for article (PubMed ID: 30774819)
1. The critical role of injecting drug users on the spatial distribution of hepatitis C virus; a study in the West of Iran.
Azizi Jalilian F; Parvin M; Olfatifar M; Erfani H; Bathaei J
Gastroenterol Hepatol Bed Bench; 2018; 11(Suppl 1):S129-S133. PubMed ID: 30774819
[TBL] [Abstract][Full Text] [Related]
2. Clustering of Pulmonary Tuberculosis in Hamadan Province, western Iran: A Population Based Cross Sectional Study (2005-2013).
Olfatifar M; Karami M; Hosseini SM; Parvin M
J Res Health Sci; 2016; 16(3):166-169. PubMed ID: 27840346
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Clusters and Non-Clusters Areas of Attempted Suicide Cases in Hamadan Province, Western Iran: Findings from a Pilot Study (2016-2017).
Karami M; Yazdi-Ravandi S; Ghaleiha A; Olfatifar M
J Res Health Sci; 2018 Aug; 18(3):e00425. PubMed ID: 30270217
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
[TBL] [Abstract][Full Text] [Related]
5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
[TBL] [Abstract][Full Text] [Related]
9. HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.
Sultana C; Vagu C; Temereanca A; Grancea C; Slobozeanu J; Ruta S
Cent Eur J Med; 2011 Oct; 6(5):672-678. PubMed ID: 23585824
[TBL] [Abstract][Full Text] [Related]
10. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran.
Keramat F; Eini P; Majzoobi MM
Iran Red Crescent Med J; 2011 Jan; 13(1):42-6. PubMed ID: 22946017
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users.
Alavian SM; Mirahmadizadeh A; Javanbakht M; Keshtkaran A; Heidari A; Mashayekhi A; Salimi S; Hadian M
Hepat Mon; 2013; 13(8):e12411. PubMed ID: 24069039
[TBL] [Abstract][Full Text] [Related]
13. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
14. Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users.
Kato H; Maeno Y; Seko-Nakamura Y; Monma-Ohtaki J; Sugiura S; Takahashi K; Zhe LX; Matsumoto T; Kurvanov F; Mizokami M; Nagao M
Forensic Sci Int; 2007 May; 168(1):27-33. PubMed ID: 16829004
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic.
Mravčík V; Strada L; Reimer J; Schulte B
Epidemiol Mikrobiol Imunol; 2014 Nov; 63(4):265-9. PubMed ID: 25523218
[TBL] [Abstract][Full Text] [Related]
16. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
18. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
Miller M; Mella I; Moi H; Eskild A
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India.
Basu D; Sharma AK; Gupta S; Nebhinani N; Kumar V
Indian J Med Res; 2015 Sep; 142(3):311-6. PubMed ID: 26458347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
